Japan Second Committee On Drugs Approves 7 New Medications
This article was originally published in PharmAsia News
Executive Summary
MHLW Japan’s PAFSC Second Committee on Drugs approved seven new medications on April 30, including the inhaled LAMA/LABA formulation Anoro Ellipta (umeclidinium and vilanterol) used for COPD treatment from GSK.